Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?

Zeeshan Mansuri; Bhumika Shah; Garima Yadav; Sahar Hooda Kamil; Tejasvi Kainth; Sushma Srinivas; Hiren Patel; Abhishek Reddy; Anil Bachu

doi:10.4088/PCC.23lr03607

Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?

Zeeshan Mansuri
, Bhumika Shah
, Garima Yadav
, Sahar Hooda Kamil
, Tejasvi Kainth
, Sushma Srinivas
, Hiren Patel
, Abhishek Reddy
, Anil Bachu

Department of Psychiatry and Behavioral Health

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Article number	23lr03607
Journal	Primary Care Companion for CNS Disorders
Volume	26
Issue number	1
DOIs	https://doi.org/10.4088/PCC.23lr03607
State	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health

Access to Document

10.4088/PCC.23lr03607

Cite this

@article{fbf1009ee3514969b2fe159c4c6b5de0,

title = "Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?",

author = "Zeeshan Mansuri and Bhumika Shah and Garima Yadav and Kamil, \{Sahar Hooda\} and Tejasvi Kainth and Sushma Srinivas and Hiren Patel and Abhishek Reddy and Anil Bachu",

year = "2024",

doi = "10.4088/PCC.23lr03607",

language = "English (US)",

volume = "26",

journal = "Primary Care Companion for CNS Disorders",

issn = "2155-7780",